Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations
Condition(s):Pulmonary Disease, Chronic Obstructive; Exacerbation CopdLast Updated:April 26, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Pulmonary Disease, Chronic Obstructive; Exacerbation CopdLast Updated:April 26, 2023Recruiting
Condition(s):COPD ExacerbationLast Updated:December 27, 2023Recruiting
Condition(s):Chronic Obstructive Pulmonary Disease (COPD)Last Updated:December 26, 2023Not yet recruiting
Condition(s):COPD ExacerbationLast Updated:March 10, 2023Not yet recruiting
Condition(s):Oxygen Deficiency; COPD ExacerbationLast Updated:April 4, 2023Recruiting
Condition(s):Sarcopenia; COPD ExacerbationLast Updated:May 13, 2021Completed
Condition(s):COPD Exacerbation; EosinophiliaLast Updated:July 14, 2021Recruiting
Condition(s):Pneumococcal Infections; COPDLast Updated:April 27, 2023Terminated
Condition(s):COPD ExacerbationLast Updated:August 31, 2015Unknown status
Condition(s):Asthma; COPDLast Updated:December 6, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.